Doxorubicin-Induced Cardiomyopathy Latest Advances

Therapeutic effect of Fuzheng Yixin decoction on cardiac insufficiencythe soluble guanylyl cyclase-cyclic guanosine monophosphate-protein kinase G pathway in a doxorubicin-induced dilated cardiomyopathy rat model.

Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan

Published: August 25, 2026

Retraction of The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.

Journal: The Journal of clinical investigation

Published: August 17, 2026

Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 06, 2026

Meta-Analysis of Genome-Wide Association Studies of Doxorubicin-Induced Arrhythmia Identifies MMP16 and KCTD15 as Risk Loci.

Journal: Circulation. Genomic and precision medicine

Published: July 29, 2026

Third-Space Entrapment of Methotrexate in Anthracycline-Induced Cardiomyopathy: The First Complete Case Trajectory From Toxicity to Rescue Failure.

Journal: Cureus

Published: July 28, 2026

CX3CR1+ macrophages aggravate doxorubicin-induced cardiomyopathy by impairing cardiac mitophagy via the CSF1R-PARP1-IL1B axis.

Journal: Autophagy

Published: July 24, 2026

Cardioprotective effect of natural products on doxorubicin-induced cardiotoxicity and cardiac ischemia-reperfusion injury: A focus on ion channels modulation.

Journal: Current topics in membranes

Published: July 10, 2026

Interplay of oxidative stress and inflammatory mechanisms in doxorubicin-induced cardiomyopathy.

Journal: American journal of physiology. Heart and circulatory physiology

Published: July 02, 2026

A STING-mediated trialogue: co-ordinating the CD8+ T-cell assault in doxorubicin cardiomyopathy.

Journal: Cardiovascular research

Published: June 26, 2026

PAD4 inhibitor GSK484 alleviates doxorubicin-induced myocardial fibrosis by modulating profibrotic, inflammatory and apoptotic signaling pathways in mice.

Journal: European journal of pharmacology

Published: June 12, 2026

Does exercise modulate ferroptosis-related cardiovascular injury? Mechanistic evidence and translational boundaries.

Journal: Frontiers in physiology

Published: June 04, 2026

Loeffler's Endomyocarditis With Embolic Stroke Secondary to Chronic Eosinophilic Leukemia With Therapy-Related Molecular Features.

Journal: JACC. Case reports

Published: June 04, 2026

Doxorubicin-Induced Cardiomyopathy Latest Advances

Find the Latest Research About Doxorubicin-Induced Cardiomyopathy

Therapeutic effect of Fuzheng Yixin decoction on cardiac insufficiencythe soluble guanylyl cyclase-cyclic guanosine monophosphate-protein kinase G pathway in a doxorubicin-induced dilated cardiomyopathy rat model.

Therapeutic effect of Fuzheng Yixin decoction on cardiac insufficiencythe soluble guanylyl cyclase-cyclic guanosine monophosphate-protein kinase G pathway in a doxorubicin-induced dilated cardiomyopathy rat model.

Retraction of The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.

Retraction of The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.

Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2.

Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2.

Meta-Analysis of Genome-Wide Association Studies of Doxorubicin-Induced Arrhythmia Identifies MMP16 and KCTD15 as Risk Loci.

Meta-Analysis of Genome-Wide Association Studies of Doxorubicin-Induced Arrhythmia Identifies MMP16 and KCTD15 as Risk Loci.

Third-Space Entrapment of Methotrexate in Anthracycline-Induced Cardiomyopathy: The First Complete Case Trajectory From Toxicity to Rescue Failure.

Third-Space Entrapment of Methotrexate in Anthracycline-Induced Cardiomyopathy: The First Complete Case Trajectory From Toxicity to Rescue Failure.

CX3CR1+ macrophages aggravate doxorubicin-induced cardiomyopathy by impairing cardiac mitophagy via the CSF1R-PARP1-IL1B axis.

CX3CR1+ macrophages aggravate doxorubicin-induced cardiomyopathy by impairing cardiac mitophagy via the CSF1R-PARP1-IL1B axis.

Cardioprotective effect of natural products on doxorubicin-induced cardiotoxicity and cardiac ischemia-reperfusion injury: A focus on ion channels modulation.

Cardioprotective effect of natural products on doxorubicin-induced cardiotoxicity and cardiac ischemia-reperfusion injury: A focus on ion channels modulation.

Interplay of oxidative stress and inflammatory mechanisms in doxorubicin-induced cardiomyopathy.

Interplay of oxidative stress and inflammatory mechanisms in doxorubicin-induced cardiomyopathy.

A STING-mediated trialogue: co-ordinating the CD8+ T-cell assault in doxorubicin cardiomyopathy.

A STING-mediated trialogue: co-ordinating the CD8+ T-cell assault in doxorubicin cardiomyopathy.

PAD4 inhibitor GSK484 alleviates doxorubicin-induced myocardial fibrosis by modulating profibrotic, inflammatory and apoptotic signaling pathways in mice.

PAD4 inhibitor GSK484 alleviates doxorubicin-induced myocardial fibrosis by modulating profibrotic, inflammatory and apoptotic signaling pathways in mice.

Does exercise modulate ferroptosis-related cardiovascular injury? Mechanistic evidence and translational boundaries.

Does exercise modulate ferroptosis-related cardiovascular injury? Mechanistic evidence and translational boundaries.

Loeffler's Endomyocarditis With Embolic Stroke Secondary to Chronic Eosinophilic Leukemia With Therapy-Related Molecular Features.

Loeffler's Endomyocarditis With Embolic Stroke Secondary to Chronic Eosinophilic Leukemia With Therapy-Related Molecular Features.